LGC Maine Standards announces VALIDATE® SP1 kit, now specifically targeted for Roche cobas® and Roche COBAS INTEGRA® analyzers

Share Article

VALIDATE® SP1, specifically targeted for Roche cobas® and Roche COBAS INTEGRA® analyzers, used in conjunction with VALIDATE® SP2 & SP3, offers easy, fast, efficient linearity and calibration verification of Serum Proteins.

News Image

LGC Maine Standards releases VALIDATE® SP1 linearity and calibration verification kit, specifically targeted for Roche cobas® and Roche COBAS INTEGRA® analyzers, Order No. 601ro. The kit, in a human-serum matrix, evaluates α1-Antitrypsin (ATT), Complement C3 (C3), Complement C4 (C4), Immunoglobulin A (IGA), Immunoglobulin G (IGG), Immunoglobulin M (IGM), and Transferrin (TRFN). Each VALIDATE® SP1 kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal delta” sample preparation, offers five distinct concentrations covering the reportable range. Simply dispense the solution from each dropper bottle, directly into five sample cups, and run in replicates.

VALIDATE® SP1 (601ro), for Roche cobas® and Roche COBAS INTEGRA® users, complements our existing VALIDATE® SP2 (Order No. 602re) & SP3 (Order No. 603ro) products, which target recoveries for ALB, CER, CRP, HPT, PAB, RF, and AAG, ASO, B2M, IGE, respectively. Together, our Serum Protein VALIDATE® offerings provide 17 analytes for easy, fast, and efficient linearity and calibration verification testing – maximizing the reportable range, while minimizing manual dilutions. Use of these products, while augmenting daily QC, assists with fulfilling various quality control requirements – such as Reportable Range and Analytical Measurement Range (AMR) – for linearity and calibration verification under CLIA ‘88, CAP, COLA, JCAHO, JCI and ISO 15189.

The addition of VALIDATE® SP1, for Roche cobas® and Roche COBAS INTEGRA® analyzers, to the LGC Maine Standards expanding portfolio of products, demonstrates a continued commitment to manufacture high-quality linearity and calibration verification products that meet industry needs.

LGC Maine Standards is located in Cumberland Foreside, Maine and manufactures VALIDATE® linearity and calibration verification kits for over 140 analytes, including General Chemistries, Urine Chemistries, Body Fluid Chemistries, Enzymes, Lipoproteins, HbA1c, Therapeutic Drugs, Cardiac Markers, Thyroids, Serum Proteins, Vitamin D, Tumor Markers, Anemia, Fertility, Hemostasis and Whole Blood Glucose.

LGC Maine Standards MSDRx® data reduction software is available at no charge for real-time data analysis or a laboratory can send their data to LGC Maine Standards where a technical specialist will complete the data analysis and return a report within five business days. Peer group comparison is also available upon request.

Contact: Maine Standards Company, LLC
     221 US Route 1, Cumberland Foreside, ME 04110
                 1-207-892-1300 x1473
     Adriano.Ciccomancini@LGCGroup.com
http://www.mainestandards.com

About LGC
LGC is an international life sciences measurement and testing company with leading positions in growing markets. LGC provides a range of measurement products and services which underpin the safety, health and security of the public, including reference materials and proficiency testing, calibration verification / linearity testing, genomics reagents and instrumentation, and expert sample analysis and interpretation. LGC serves customers across a number of end markets including Pharmaceuticals, Agricultural Biotechnology, Food, Environment, Government and Academia. LGC’s headquarters are in London and the company employs over 2,000 people, operating out of 22 countries worldwide. Its operations are extensively accredited to international quality standards such as ISO/IEC 17025, GMP, GLP, ISO Guide 34, ISO/IEC 17043 and ISO 13485:2016. With a history dating back to 1842, LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement. LGC was privatized in 1996 and is now owned by funds affiliated with KKR. For more information, please visit http://www.lgcgroup.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Adriano Ciccomancini
Visit website